» Articles » PMID: 23315062

Vitrification Preserves Proliferation Capacity in Human Spermatogonia

Overview
Journal Hum Reprod
Date 2013 Jan 15
PMID 23315062
Citations 46
Authors
Affiliations
Soon will be listed here.
Abstract

Study Question: Does vitrification of human immature testicular tissue (ITT) have potential benefits for future fertility preservation? Does vitrification of human ITT have potential benefits in an in vivo murine xenotransplantation model?

Summary Answer: Vitrification is able to maintain proliferation capacity in spermatogonial cells after 6 months of xenografting.

What Is Known Already: Controlled slow-freezing is the procedure currently applied for ITT cryobanking in clinical practice. Vitrification has been proposed as a promising technique for long-term storage of ITT, with a view to preserving spermatogonial stem cells (SSCs) for future fertility restoration in young boys suffering from cancer. After vitrification of ITT, in vitro survival of SSCs was demonstrated, but their functionality was not evaluated.

Study Design, Size, Duration: Ten ITT pieces issuing from 10 patients aged 2-12 years were used. Fragments of fresh tissue (serving as controls) and fresh, frozen-thawed and vitrified-warmed testicular pieces xenografted to the scrotum of nude mice for 6 months were compared.

Materials, Setting, Methods: Upon graft removal, histological and immunohistochemical analyses were performed to evaluate spermatogonia (SG) (MAGE-A4), intratubular proliferation (Ki67), proliferating SG and Leydig cells (3β-HSD). The entire piece of grafted tissue was assessed in each case.

Main Results And The Role Of Chance: Seminiferous tubules showed good integrity after cryopreservation and xenografting for 6 months in all three groups. Survival of SG and their ability to proliferate was observed by immunohistochemistry in all grafted groups. SG were able to initiate spermatogenesis, but blockage at the pachytene stage was observed. The recovery rate of SG was 3.4 ± 3.8, 4.1 ± 7.3 and 7.3 ± 6.3%, respectively, for fresh, slow-frozen and vitrified-warmed tissue after 6 months of xenografting.

Limitations, Reasons For Caution: The study is limited by the low availability of ITT samples of human origin. The mouse xenotransplantation model needs to be refined to study human spermatogenesis.

Wider Implications Of The Findings: The findings of the present study have potential implications for cryobanking of ITT and fertility preservation. Spermatogonial loss recorded after fresh ITT transplantation indicates that the avascular grafting technique needs to be optimized. There are so far no convincing data justifying modification of current clinical practice for ITT storage with slow-freezing, but this study demonstrates that it is worth pursuing optimization of ITT vitrification as an alternative for preservation of SSCs.

Study Funding/competing Interest(s): The present study was supported by a grant from the Fonds National de la Recherche Scientifique de Belgique (grant Télévie N° 7. 4.572.09.F). The authors declare that there is no conflict of interest.

Citing Articles

REPRODUCTIVE HEALTH IN TRANS AND GENDER-DIVERSE PATIENTS: Gonadal tissue cryopreservation in transgender and gender-diverse people.

Ausavarungnirun C, Orwig K Reproduction. 2024; 168(6).

PMID: 39331789 PMC: 11623121. DOI: 10.1530/REP-24-0253.


The Low Survivability of Transplanted Gonadal Grafts: The Impact of Cryopreservation and Transplantation Conditions on Mitochondrial Function.

Moniz I, Soares M, Sousa A, Ramalho-Santos J, Branco A Biology (Basel). 2024; 13(7).

PMID: 39056734 PMC: 11274302. DOI: 10.3390/biology13070542.


Advancements in fertility preservation strategies for pediatric male cancer patients: a review of cryopreservation and transplantation of immature testicular tissue.

Sung Z, Liao Y, Hou J, Lai H, Weng S, Jao H Reprod Biol Endocrinol. 2024; 22(1):47.

PMID: 38637872 PMC: 11025181. DOI: 10.1186/s12958-024-01219-5.


Optimizing Immature Testicular Tissue and Cell Transplantation Results: Comparing Transplantation Sites and Scaffolds.

Anvari A, Movahedin M, Hamzeh M Int J Fertil Steril. 2023; 18(1):12-19.

PMID: 38041454 PMC: 10692742. DOI: 10.22074/ijfs.2023.559999.1350.


A comprehensive review and update on human fertility cryopreservation methods and tools.

Antonouli S, Di Nisio V, Messini C, Daponte A, Rajender S, Anifandis G Front Vet Sci. 2023; 10:1151254.

PMID: 37143497 PMC: 10151698. DOI: 10.3389/fvets.2023.1151254.